Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 78
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02663609 | Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome | ||
| NCT03315338 | First-in-human Study in Healthy Subjects | ||
| NCT06928779 | Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant | ||
| NCT05117489 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT03540836 | A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants | ||
| NCT03508635 | CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) | ||
| NCT04308590 | A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas | ||
| NCT03335956 | CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) | ||
| NCT03697109 | A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome | ||
| NCT03604198 | Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome | ||
| NCT02014337 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | ||
| NCT01925092 | Mifepristone in Children With Refractory Cushing's Disease | ||
| NCT05003713 | Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants | ||
| NCT03818256 | A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications | ||
| NCT06947304 | Evaluation of Miricorilant on Liver Fat in Patients With MASLD | ||
| NCT00130676 | A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression | ||
| NCT04795479 | T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers | ||
| NCT05553470 | Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant | ||
| NCT04990310 | Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants | ||
| NCT05320146 | A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT06495944 | Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants | ||
| NCT04329949 | Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT06094790 | A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects | ||
| NCT07276373 | Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies | ||
| NCT02922257 | Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery | ||
| NCT04994743 | Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants | ||
| NCT02762981 | Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors | ||
| NCT04524403 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II) | ||
| NCT03258372 | Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites | ||
| NCT03877562 | The Effect of CORT118335 on Olanzapine-Induced Weight Gain | ||
| NCT06689254 | REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism | ||
| NCT06094712 | A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects | ||
| NCT00208156 | A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression | ||
| NCT04249323 | Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants | ||
| NCT03442621 | Relacorilant Food Effect Study in Healthy Subjects | ||
| NCT03379363 | Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome | ||
| NCT04672499 | Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants | ||
| NCT05257408 | Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer | ||
| NCT01371565 | Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome | ||
| NCT00105105 | Mifepristone as Adjunctive Therapy in Alzheimer's Disease | ||
| NCT00146523 | An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression | ||
| NCT00128479 | A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression | ||
| NCT06099769 | A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer | ||
| NCT00698022 | A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers | ||
| NCT00569582 | A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome | ||
| NCT03067376 | A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body | ||
| NCT07259317 | Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma | ||
| NCT03259542 | Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor | ||
| NCT03674814 | Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer | ||
| NCT00455442 | A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain |
